changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.
For Medical questions regarding any BTG products, please contact email@example.com
The EkoSonic™ Endovascular System is the only device cleared by the FDA for the treatment of Pulmonary Embolism.
In a recent study, patients receiving EKOS™ therapy had 52% shorter hospital length of stay vs patients receiving anticoagulation alone.17
The EkoSonic™ Endovascular System dissolves thrombus more completely, even behind valves and IVC filters.9
EKOS™ therapy quickly restores blood flow, potentially reducing the risk of pulmonary embolism and post-thrombotic syndrome (PTS).
The EkoSonic™ Endovascular System safely accelerates drug penetration and clot dissolution.
Compared to traditional PAO treatment (standard CDT) EKOS therapy offers:
-Reduced treatment times
-Lower amputation rates
-Shorter hospitals stays2
24 Hour Technical Service Help 888-356-7435
(888 EKOS HELP)
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com